Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search
Page Menu

COVID-19 research

Getting Results…
  • UMass Medical School researchers to evaluate treatment options for early COVID-19 infection
    Research News

    UMass Medical School researchers to evaluate treatment options for early COVID-19 infection

    UMass Medical School is participating in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which is evaluating investigational agents for treating early COVID-19.

    Read more
  • UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies
    Research News

    UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies

    The national effort to bring convenient, affordable and rapid testing technology for SARS-CoV-2 infection to market is moving full speed ahead. The $1.5 billion effort was launched a year ago, with UMass Medical School playing a major role in coordinating the push for fast, accessible COVID-19 testing.

    Read more
  • U.S. News & World Report ranks UMass Medical School 10th in the nation in primary care education
    Education News

    U.S. News & World Report ranks UMass Medical School 10th in the nation in primary care education

    UMass Medical School ranks 10th nationwide in primary care by U.S. News & World Report in its annual rankings of the best graduate schools. The 2022 report also marks a rise for UMMS in research, this year ranking 45th, up two spots from the previous ranking.

    Read more
  • New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19
    Research News

    New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19

    New research by Kaleido Biosciences, Inc., and UMass Medical School’s John P. Haran, MD, PhD, and Beth McCormick, PhD, shows that the company’s microbiome metabolic therapy candidate produced positive results in patients with mild-to-moderate COVID-19.

    Read more
  • Breast and prostate cancer screenings dropped during COVID-19 pandemic, UMMS study finds
    Research News

    Breast and prostate cancer screenings dropped during COVID-19 pandemic, UMMS study finds

    Breast and prostate cancer screenings declined rapidly in the early months of the COVID-19 pandemic compared with the same period a year earlier, according to a new study by UMass Medical School researchers working with Reliant Medical Group.

    Read more
  • UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens
    Research News

    UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens

    UMass Medical School researchers are about to start enrolling adolescents ages 12 through 17 in a clinical trial to test the COVID-19 mRNA vaccine made by Moderna.

    Read more
  • A healthy microbiome builds a strong immune system that could help defeat COVID-19
    Research News

    A healthy microbiome builds a strong immune system that could help defeat COVID-19

    In a piece written for The Conversation, Ana Maldonado-Contreras, PhD, explains why the army of microbes living inside your gut is essential for fighting off threats, including the virus that causes COVID-19.

    Read more
  • Researchers to study health care providers’ influence on COVID-19 vaccine acceptance
    Research News

    Researchers to study health care providers’ influence on COVID-19 vaccine acceptance

    Kimberly Fisher, MD, and Kathleen Mazor, EdD, are preparing a study to evaluate ways for health care providers to talk with their patients about the new COVID-19 vaccines and support them in getting vaccinated.

    Read more
  • Student-led virtual wellness program provides companionship to older, hospitalized COVID patients
    Education News

    Student-led virtual wellness program provides companionship to older, hospitalized COVID patients

    A new companionship wellness initiative at UMass Medical School is combating isolation and loneliness among COVID-19 patients 65 and older by having students virtually check in, comfort and emotionally support them at two Worcester hospitals.

    Read more
  • Robert Finberg details next steps for COVID vaccine
    Research News

    Robert Finberg details next steps for COVID vaccine

    Robert W. Finberg, MD, a member of Gov. Charlie Baker’s COVID-19 Vaccine Advisory Group, explains the process of getting the population vaccinated that will play out in phases over the coming year.

    Read more
  • New study co-authored by MD/PhD student Benjamin Helfand shows frequent delirium in older COVID patients
    Research News

    New study co-authored by MD/PhD student Benjamin Helfand shows frequent delirium in older COVID patients

    MD/PhD student Benjamin Helfand is co-first author on a study published in the Journal of American Medical Association Network Open that examines the frequency of COVID-19 positive older adults presenting to the emergency department with delirium.

    Read more
  • Women in Science: Ana Maldonado-Contreras pivots gut microbiome studies to tackle COVID-19
    Media, Research News

    Women in Science: Ana Maldonado-Contreras pivots gut microbiome studies to tackle COVID-19

    Ana Maldonado-Contreras, PhD, studies the gut microbiome and chronic disease, in particular inflammatory bowel disease, and is now working to understand how gut microbes can predispose patients to severe COVID complications.

    Read more
  • COVID-19 vaccine trial reports high effectiveness; UMass Medical School key enrollment site
    Research News

    COVID-19 vaccine trial reports high effectiveness; UMass Medical School key enrollment site

    First results from a Pfizer and BioNTech Phase III messenger RNA COVID-19 vaccine trial, in which UMass Medical School is participating, show promising findings, with more than 90 percent effectiveness in preventing infection with the SARS-CoV-2 virus, the companies announced.

    Read more
  • Sarah Nicole Forrester, Ann Moormann awarded $2 million NCI SeroNet grant
    Research News

    Sarah Nicole Forrester, Ann Moormann awarded $2 million NCI SeroNet grant

    Sarah Nicole Forrester, PhD, and Ann Moormann, PhD, MPH, are co-principal investigators on a new grant aimed at enhancing representation of Black and Hispanic people in SARS-CoV-2 immunology research through the use of storytelling.

    Read more
  • More than half of COVID-19 clinical trials exclude older adults, according to research co-authored by MD/PhD student Benjamin Helfand
    Research News

    More than half of COVID-19 clinical trials exclude older adults, according to research co-authored by MD/PhD student Benjamin Helfand

    A research letter published in JAMA Internal Medicine, co-authored by UMass Medical School MD/PhD student Benjamin Helfand, reports that older adults were likely to be excluded from more than 50 percent of COVID-19 clinical trials and 100 percent of vaccine trials initiated early in the pandemic.

    Read more
  • UMMS researchers study attitudes toward potential COVID-19 vaccine
    Research News

    UMMS researchers study attitudes toward potential COVID-19 vaccine

    As many as four in 10 adults would refuse or hesitate to get a COVID-19 vaccine, according to a national survey, results of which were published in the Annals of Internal Medicine. Study co-authors Kimberly Fisher, MD, and Kathleen Mazor, EdD, say the findings indicate that health education outreach would be necessary to achieve widespread uptake of a safe and effective vaccine.

    Read more
  • Boston Globe, CNN: UMass Medical School seeking to enroll diverse communities in COVID vaccine trial
    Media, Research News

    Boston Globe, CNN: UMass Medical School seeking to enroll diverse communities in COVID vaccine trial

    Robert Finberg, MD, spoke with the Boston Globe and CNN about measures UMass Medical School has taken to reach a diverse population as it recruits for its involvement in the Pfizer/ BioNTech vaccine trail for COVID-19.

    Read more
  • UMass Medical School announces participation and enrollment for vaccine trial candidate against COVID-19
    Research News

    UMass Medical School announces participation and enrollment for vaccine trial candidate against COVID-19

    UMass Medical School is enrolling healthy volunteers to take part in a Phase II/III clinical trial testing whether a messenger RNA vaccine candidate can prevent infection with the virus that causes COVID-19.

    Read more
  • Genomic analysis reveals many species may be vulnerable to SARS-CoV-2
    Research News

    Genomic analysis reveals many species may be vulnerable to SARS-CoV-2

    A new study from scientists at UMass Medical School and the University of California, Davis, reveals that humans are not the only species facing a potential threat from SARS-CoV-2, the novel coronavirus that causes COVID-19.

    Read more
  • UMass Medical School receives $100 million in NIH grants to lead push for fast, accessible COVID-19 tests
    Research News

    UMass Medical School receives $100 million in NIH grants to lead push for fast, accessible COVID-19 tests

    UMass Medical School has been awarded grants totaling more than $100 million to coordinate the nationwide push for fast, accessible COVID-19 testing, playing a major role in the National Institutes of Health’s Rapid Acceleration of Diagnostics, or RADx, program.

    Read more
  • Greater Worcester COVID-19 Community Health Survey underway
    Community News

    Greater Worcester COVID-19 Community Health Survey underway

    UMass Medical School is conducting a community-facing survey in Worcester and six surrounding communities to assess how COVID-19 has affected ongoing day-to-day needs and help localities target relief efforts.

    Read more
  • Katherine Fitzgerald and Anastasia Khvorova named Harrington Scholars
    Research News

    Katherine Fitzgerald and Anastasia Khvorova named Harrington Scholars

    The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, in collaboration with Morgan Stanley GIFT Cures, has chosen two UMass Medical School faculty members to receive Harrington Scholar Awards for Coronavirus.

    Read more
  • UMass Medical School and UMass Memorial create risk scoring tool to triage COVID-19 patients
    Research News

    UMass Medical School and UMass Memorial create risk scoring tool to triage COVID-19 patients

    David McManus, MD, and MD/PhD candidate Apurv Soni developed a tool to predict risk of severe illness in COVID-19 patients.

    Read more
  • UMass Medical School researchers ramp up COVID-19 convalescent plasma study
    Research News

    UMass Medical School researchers ramp up COVID-19 convalescent plasma study

    More than 100 critically ill COVID-19 patients in the UMass Memorial Health Care system have been treated with convalescent plasma through a UMass Medical School clinical trial led by Jonathan M. Gerber, MD.

    Read more
  • Virus-like particles developed for RSV may hold key to COVID-19 vaccine, UMMS researcher says
    Research News

    Virus-like particles developed for RSV may hold key to COVID-19 vaccine, UMMS researcher says

    Trudy Morrison, PhD, is the featured speaker at the Hudson Hoagland Society’s 35th annual meeting, to be held virtually on Wednesday, May 20.

    Read more
  • Mass Consortium on Pathogen Readiness awards COVID-19 research funding to three UMass Medical School projects
    Research News

    Mass Consortium on Pathogen Readiness awards COVID-19 research funding to three UMass Medical School projects

    Research into COVID-19 by UMass Medical School scientists Ann Moormann, PhD, MPH; Robert Finberg, MD; and Jeremy Luban, MD, is being funded by the Massachusetts Consortium on Pathogen Readiness.

    Read more
  • NIH invests in rapid innovation and development for COVID-19 testing
    Research News

    NIH invests in rapid innovation and development for COVID-19 testing

    The Center for Advancing Point of Care Technologies, co-directed by David McManus, MD, at UMass Medical School, will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies.

    Read more
  • Telegram: Robert Finberg explains UMass Medical School role in promising COVID-19 drug trial
    Research News

    Telegram: Robert Finberg explains UMass Medical School role in promising COVID-19 drug trial

    Thirty-one patients with severe COVID-19 were enrolled in the randomized, controlled trial of the drug remdesivir at UMass Memorial Medical Center’s University and Memorial campuses, overseen by lead investigator Robert W. Finberg, MD.

    Read more
  • Fujifilm announces a Phase II clinical trial of influenza antiviral drug for COVID-19
    Research News

    Fujifilm announces a Phase II clinical trial of influenza antiviral drug for COVID-19

    Fujifilm Corporation announced the initiation of a Phase II clinical trial in the United States to evaluate the safety and efficacy of its antiviral drug Avigan for patients with COVID-19, in collaboration with Brigham and Women’s Hospital, Massachusetts General Hospital and UMass Medical School. Robert W. Finberg, MD, is the principal investigator for the UMMS site.

    Read more